20449 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
Sub-classes:SOLID FORMS OF AN ORALLY-DELIVERED BETA-LACTAMASE INHIBITOR AND USES THEREOF
#2GENE EXPRESSION-BASED IDENTIFICATION OF EARLY LYME DISEASE
#3HEART VALVE PROSTHESES WITH A DRUG ELUTING MECHANISM
#4METHODS OF DIAGNOSING OR TREATING LYME DISEASE
#5BETA-LACTOMASE INHIBITORS AND USES THEREOF
#6COMPOSITION FOR IMPROVING DRUG SENSITIVITY OF ANTIBACTERIAL DRUG TO METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA), COMPOSITION FOR TREATING OR PREVENTING MRSA INFECTION, AND COMPOSITION FOR REDUCING VIRULENCE OF MRSA
#7Electro Magnetic Transducer Network in the Enhancement of Anti-infective Strategies
#8PEPTIDE-BASED BIOMARKERS AND RELATED ASPECTS FOR DISEASE DETECTION
#9Antibiotic Topical Composition for Absorption into Systemic Bloodstream
#10PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION
#11METHODS FOR TREATING HYPERVIRULENT KLEBSIELLA PNEUMONIAE INFECTION
#12BORONIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF
#13IONIC LIQUIDS FOR TRANSDERMAL DRUG DELIVERY
#14Treatment of rhinosinusitis with P-glycoprotein inhibitors
#15TREATMENT FOR CELLULITIS AND PRE-OPERATIVE TREATMENT
#16METHODS OF TREATMENT COMPRISING STABLE REDUCED GLUTATHIONE
#17METHODS AND COMPOSITIONS FOR ATTENUATING ANTIBIOTIC RESISTANCE
#18MODIFIED BETA-LACTAMASES AND METHODS AND USES RELATED THERETO
#19Processes for preparing a diazabicyclooctane compound
#20EFFERVESCENT GEL DRY POWDER FORMULATION AND PREPARATION METHOD THEREOF
#21Therapeutic bacteriophage compositions for treating infection
#22HYDRATE ACCELERATOR, HYDRATE AND PREPARATION METHOD THEREOF
#23MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#24NOVEL SUBTITUTED SULFONYLUREA AND SULFOXIMINEUREA DERIVATIVES
#25SUSTAINED RELEASE OF ANTIINFECTIVES
#26ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION COMPRISING PROBIOTICS AND ANTIBIOTICS, AND METHOD USING SAME
#27Therapeutic use of levorotatory β-lactams in hematopoiesis, immuno-oncology therapy, and regulation of lipoprotein and apolipoprotein levels
#28ANTI-INFECTION EFFECTS OF HNRNPA2B1 AND USE THEREOF
#29LIPID OLIGONUCLEOTIDE ANTISENSE AGAINST ANTIBIOTIC RESISTANCE
#30Treatment for cellulitis and pre-operative treatment
#31SOLID FORMS OF AN ORALLY-DELIVERED BETA-LACTAMASE INHIBITOR AND USES THEREOF
#32MULTICOMPONENT CRYSTAL FORMULATIONS
#33Materials and Methods for Enhanced Treatment and Prevention of Biofilms
#34MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#35COMBINATION COMPOSITIONS COMPRISING A BETA-LACTAMASE INHIBITOR AND USES THEREOF
#36Combination comprising zidovudine and an antimicrobial compound
#37MODIFIED BETA-LACTAMASES AND METHODS AND USES RELATED THERETO
#38SUSTAINED RELEASE OF ANTIINFECTIVES
#39BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, INCLUDING TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES
#40Deimmunized lysostaphin and methods of use
#41Drug-loaded nanofiber membrane, method for preparing the same, and application thereof
#42NANOEMULSION COMPOSITIONS HAVING ENHANCED PERMEABILITY
#43New use of R-enantiomer of adrenergic beta 2 receptor agonists for treatment of inflammatory bowel disease and its extra intestinal manifestations
#44SYRINGE FOR RECONSTITUTING AND INJECTING A PHARMACEUTICAL SOLUTION
#45Processes for preparing a diazabicyclooctane compound
#46Boronic acid derivatives and therapeutic uses thereof
#47NOVEL HYDROGEL CONJUGATES
#48Treatment of rhinosinusitis with p-glycoprotein inhibitors
#49WOUND PREVENTION AND/OR TREATMENT AND RELATED COMPOUNDS, MATRICES, COMPOSITIONS, METHODS AND SYSTEMS
#50Potentiation of β-lactam antibiotics and β-lactam/β-lactamase inhibitor combinations against multidrug and extensively drug-resistant using non-ribosomal tobramycin-cyclam conjugates
#51Drug-Eluting Spacer for Joints of the Human Body
#52Compositions containing exosome carrying NF-κB inhibitors and methods of using thereof
#53Heterocyclic compounds and their use in preventing or treating bacterial infections
#54Chromogenic beta-lactamase substrate
#55ANTIBIOTIC COMPOSITIONS AND METHODS OF USE
#56Platform drug delivery system utilizing crystal engineering and theanine dissolution
#57SUSTAINED RELEASE OF ANTIINFECTIVES
#58GLUTAMATE AGENTS IN THE TREATMENT OF MENTAL DISORDERS
#59GLUTAMATE AGENTS IN THE TREATMENT OF MENTAL DISORDERS
#60Therapeutic use of levorotatory β-lactams in hematopoiesis, immuno-oncology therapy, and regulation of lipoprotein and apolipoprotein levels
#61Macrocyclic broad spectrum antibiotics
#62PROBIOTIC RECOLONISATION THERAPY
#63pH-Modulated Formulations for Pulmonary Delivery
#64Beta-lactam compounds or salts thereof for use in long-acting prevention or treatment of a glucose metabolism disorder
#65Beta-lactam compounds or salts thereof for use in long-acting prevention or treatment of a glucose metabolism disorder
#66Methods and compositions related to STK1-targeted small molecules as antibiotic resistance breakers
#67Treatment for cellulitis and pre-operative treatment
#68Treatment of rhinosinusitis with P-glycoprotein inhibitors
#69Gel formulation for treating diabetic foot ulcer infections
#70USE OF PHENOTHIAZINE DERIVATIVE IN THE TREATMENT OF INFECTIOUS PURPURA OR PURPURA FULMINANS
#71Processes for preparing a diazabicyclooctane compound
#72Deimmunized lysostaphin and methods of use
#73COMPOSITION FOR WOUND HEALING
#74Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
#75Therapeutic use of tromethamine salt of L-ampicilline in hematopoiesis, immuno-oncology therapy, and regulation of lipoprotein and apolipoprotein levels
#76Ionic liquids for transdermal drug delivery
#77Methods of treating bacterial infections with penam β-lactam antibiotics and branched poly(ethylenimine)
#78Modulating antibacterial immunity via bacterial membrane-coated nanoparticles
#79Method of treating benign prostatic hyperlasia with antibiotics
#80NOVEL ISOFORM OF ANAPLASTIC LYMPHOMA KINASE AND ITS USES
#81Probiotic recolonisation therapy
#82SUSTAINED RELEASE OF ANTIINFECTIVES
#83Modified beta-lactamases and methods and uses related thereto
#84SUSTAINED RELEASE OF ANTIINFECTIVES
#85SUSTAINED RELEASE OF ANTIINFECTIVES
#86Methods of treating bacterial infections
#87Antibacterial composition containing ADK protein as active ingredient, or composition for preventing or treating sepsis
#88PRODUCTION METHOD AND EFFERVESCENT FORMULATIONS COMPRISING CEPHALOSPORIN AND CLAVULANIC ACID
#89Diagnostic assays and methods of treating pneumonia, sepsis and systemic inflammatory response syndrome
#90SUSTAINED RELEASE OF ANTIINFECTIVES
#91DIAGNOSIS AND TREATMENT OF INFECTIOUS DISEASE
#92Probiotic recolonisation therapy
#93Process for preparing ceftolozane from 7-aminocephalosporanic acid (7-ACA)
#94SUSTAINED RELEASE OF ANTIINFECTIVES
#95SUSTAINED RELEASE OF ANTIINFECTIVES
#96Glutamate agents in the treatment of mental disorders
#97Veterinary compositions for use in treating mastitis, and associated methods
#98BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, INCLUDING TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES
#99Beta-lactamase inhibitors
#100Antibiotic-loaded transdermal patch
#101Combination of bactericidal agent with a lysosomotropic alkalinising agent for the treatment of a bacterial infection
#102Processes for preparing a diazabicyclooctane compound
#103ANTIBACTERIAL COMPOSITIONS
#104Pharmaceutical composition containing the tromethamine salt of L-ampicillin
#105CEFTOLOZANE-TAZOBACTAM PHARMACEUTICAL COMPOSITIONS
#106Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
#107Composition for inhibiting growth or proliferation of chronic myelogenous leukemia cancer stem cells, and screening method therefor
#108SUSTAINED RELEASE OF ANTIINFECTIVES
#109Modulating antibacterial immunity via bacterial membrane-coated nanoparticles
#110PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION
#111Quinazolinone antibiotics
#112BURN OINTMENT FOR PROMOTING TISSUE REGENERATION AND SKIN GROWTH, AND PREPARATION METHOD THEREFOR
#113GLUTAMATE AGENTS IN THE TREATMENT OF MENTAL DISORDERS
#114Treatment of rhinosinusitis with P-glycoprotein inhibitors
#115Modified beta-lactamases and methods and uses related thereto
#116Anti-ar agent and radiation therapy for androgen receptor positive cancer
#117Isoxazole derivatives as FXR agonists and methods of use thereof
#118MEDICAMENT CARRIER FOR THE TREATMENT AND PREVENTION OF PATHOLOGICAL CONDITIONS IN THE UROGENITAL REGION
#119Beta-lactamase inhibitor and process for preparing the same
#120Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof
#121Modified beta-lactamases and methods and uses related thereto
#122Deimmunized lysostaphin and methods of use
#123Derivatives of cephalosporin for treating cancer
#124ENZYME-IMMOBILIZED POROUS MEMBRANE AND PREPARATION METHOD OF ANTIBIOTICS USING THE SAME
#125Macrocyclic broad spectrum antibiotics
#126Boronic acid derivatives and therapeutic uses thereof
#127Methods and Compositions for Inhibiting Clostridium difficile Spore Germination and Outgrowth
#128Isoform of anaplastic lymphoma kinase and its uses
#129Antimicrobial formulations and applications thereof
#130Probiotic recolonisation therapy
#131Probiotic recolonisation therapy
#132Probiotic recolonisation therapy
#133BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, INCLUDING TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES
#134Patch for treating and alleviating symptoms of skin diseases accompanied by effusion of blood proteins
#135Topical pharmaceutical compositions for treatment of pilonidal sinus wounds
#136pH-MODULATED FORMULATIONS FOR PULMONARY DELIVERY
#137MEANS AND METHODS FOR INCREASING ANTIBIOTIC ACTIVITY
#138Probiotic recolonisation therapy
#139Probiotic recolonisation therapy
#140Platform drug delivery system utilizing crystal engineering and theanine dissolution
#141Ionic liquids for transdermal drug delivery
#142Platform drug delivery system utilizing crystal engineering and theanine dissolution
#143Platform drug delivery system utilizing crystal engineering and theanine dissolution
#144Modified beta-lactamases and methods and uses related thereto
#145Treatment of rhinosinusitis with P-glycoprotein inhibitors
#146Ceftolozane-tazobactam pharmaceutical compositions
#147Modified beta-lactamases and methods and uses related thereto
#148Powder mixtures for antibiotic dry syrup formulations
#149Probiotic recolonisation therapy
#150Probiotic recolonisation therapy
#151Probiotic recolonisation therapy
#152Probiotic recolonisation therapy
#153Quinazolinone antibiotics
#154β-lactamase inhibitor and process for preparing the same
#155Methods and compositions for increasing antibiotic activity
#156REGULATION OF NITRIC OXIDE RELEASE AND BIOFILM DEVELOPMENT
#157Cephalosporin derivatives and methods of use
#158Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
#159Probiotic recolonisation therapy
#160Probiotic recolonisation therapy
#161Probiotic recolonisation therapy
#162Probiotic recolonisation therapy
#163Antimicrobial compositions comprising a hyaluronic acid binding peptide and a β-lactam antibiotic
#164ANTIBIOTIC COMPOSITIONS AND METHODS
#165Modified beta-lactamases and methods and uses related thereto
#166Preparations of effervescent formulations comprising cephalosporin and uses thereof
#167Beta-lactamase inhibitor and process for preparing the same
#168CRYSTALLINE FORM OF A BETA-LACTAMASE INHIBITOR
#169Pharmaceutical composition comprising sophorolipid in combination with an antibiotic
#170Modified beta-lactamases and methods and uses related thereto
#171Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
#172Ethoxyphenyl thienyl compounds and methods for the treatment of bacterial infections
#173Methods for the treatment of bacterial infections
#174Methods and compositions for applying pharmacologic agents to the ear
#175Method of treating middle ear infections
#176BETA-LACTAMASE INHIBITORS
#177Sustained release of antiinfectives
#178Antisense antiviral compound and method for treating influenza viral infection
#179Veterinary active agent application
#180Ceftolozane-tazobactam pharmaceutical compositions
#181Cephalosporin compositions and methods of manufacture
#182Resorbable oxidized cellulose embolization microspheres
#183Pharmaceutical composition
#184Ceftolozane-tazobactam pharmaceutical compositions
#185Glutamate agents in the treatment of mental disorders
#186Probiotic, Lactic Acid-Producing Bacteria and Uses Thereof
#187Composition for prevention or treatment of ischemic cardiac disease, comprising inhibitor against age-albumin synthesis or release of mononuclear phagocyte system cells as active ingredient
#188Regulation of nitric oxide release and biofilm development
#189Diagnostic assays and methods of treating pneumonia, sepsis and systemic inflammatory response syndrome
#190NOVEL ANTIBACTERIAL COMBINATION THERAPY
#191Isoxazole beta-lactamase inhibitors
#1921,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors
#1931,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors
#1941,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors
#1951,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors
#1961,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors
#1971,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitors
#198Topical pharmaceutical compositions for treatment of skin damage
#199Modified beta-lactamases and methods and uses related thereto
#200FtsZ INHIBITORS AS POTENTIATORS OF BETA-LACTAM ANTIBIOTICS AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS
#201Nanoparticulate composition containing antibiotics for intramammary administration in animals
#202NEUROTHERAPEUTIC TREATMENT FOR SEXUAL DYSFUNCTION
#203Method for inhibiting the induction of cell death by inhibiting the synthesis or secretion of age-albumin in cells of the mononuclear phagocyte system
#204Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
#205Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
#206Preparations for effervescent formulations comprising cephalosporin and uses thereof
#207Gastroretentive, extended release composition of therapeutic agent
#208CEPHALOSPORIN DERIVATIVES USEFUL AS BETA-LACTAMASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF
#209RNASE 7 AS A MARKER FOR INFECTION
#210SUPPOSITORY FOR RECTAL, VAGINAL OR URETHRAL ADMINISTRATION CONTAINING A PROBIOTIC, AN ANTIBIOTIC AND AN UNSATURATED NON-ESTERIFIED FATTY ACID
#211Cross-linked glycopeptide-cephalosporin antibiotics
#212Probiotic, lactic acid-producing bacteria
#213Preparation of bone cement compositions
#214METHOD OF MAKING CEFQUINOME PARTICLES
#215Sustained release composition of therapeutic agent
#216Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism
#217Pharmaceutical compositions for dehydrating, atrophying and eliminating pathological tissues
#218ANIMAL TREATMENT FORMULATION AND METHODS OF USE
#219Identification and application of antibiotic synergy
#220Methods and compositions for inhibiting clostridium difficile spore germination and outgrowth
#221Lanthionine synthetase component C-like proteins as molecular targets for preventing and treating diseases and disorders
#222NEUROTHERAPEUTIC TREATMENT FOR SEXUAL DYSFUNCTION
#223Method for manufacturing a porous ceramic scaffold having an organic/inorganic hybrid coating layer containing a bioactive factor
#224Methods of treating autoimmune diseases caused by small intestinal bacterial overgrowth
#225Pharmaceutical Composition for the Eradication of Helicobacter Pylori and Preparation Method Thereof
#226Antisense antiviral compound and method for treating influenza viral infection
#227Antimicrobial composition
#228Methods and Compositions for the Treatment of Cystic Fibrosis and Related Illnesses
#229Methods and compositions for the dietary management of autoimmune disorders
#230Neurotherapeutic Cephalosporin Sulfoxide and Sulfone-Containing Compositions
#231Novel Beta-Lactam Antibiotics, Methods for Their Production, and Their Use
#232METHOD FOR TREATMENT OF MACULAR DEGENERATION USING (+)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLINE-1,3-DIONE
#233Probiotic, lactic acid-producing bacteria and uses thereof
#234Probiotic, lactic acid-producing bacteria and uses thereof
#235Pharmaceutical composition
#236Biofilm prevention using lactoferrin
#237Stabilization of oily suspensions comprising hydrophobic silicas
#238Sustained release of antiinfectives
#239NEUROTHERAPEUTIC COMPOSITION AND METHOD THEREFOR
#240COMPOSITIONS AND METHODS FOR COATING ORTHOPEDIC IMPLANTS
#241PH-MODULATED FORMULATIONS FOR PULMONARY DELIVERY
#242Cross-linked glycopeptide-cephalosporin antibiotics
#243Inhibition of Bacterial Protein Production by Polyvalent Oligonucleotide Modified Nanoparticle Conjugates
#244Bactericidal anti-MRSA active pharmaceutical composition containing carbapenems
#245HISTONE ACETYL TRANSFERASE ACTIVATORS AND HISTONE DEACETYLASE INHIBITORS IN THE TREATMENT OF ALCOHOLISM
#246Pharmaceutical composition for topical application
#247FORMULATIONS COMPRISING CEFTIOFUR AND KETOPROFEN OR CEFTIOFUR AND BENZYL ALCOHOL
#248VETERINARY COMPOSITIONS FOR TREATING MASTITIS
#249Sustained Release of Antiinfectives
#250Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
#251Beta-LACTAM-CONTAINING FORMULATIONS WITH INCREASED STABILITY IN AQUEOUS SOLUTION
#252ANTIBACTERIAL COMBINATION AND ITS USE
#253Pharmaceutical compositions of Cefixime
#254Beta-lactamase inhibitory compounds
#255Methods of treating diarrhea caused by small intestinal bacterial overgrowth
#256Antibiotic combinations for providing total solution to the treatment of infections
#257Novel Combinations of DNAK Inhibitors With Known Antibacterial Agents
#258COMPOSITIONS AND METHODS FOR TREATING PERIORAL DERMATITIS
#259Cefuroxime axetil granule and process for the preparation thereof
#260Method of treating middle ear infections
#261STABLE PHARMACEUTICAL COMPOSITION COMPRISING BETA-LACTAM ANTIBIOTIC AND BUFFER
#262STABLE PHARMACEUTICAL COMPOSITIONS OF AMINOGLYCOSIDE ANTIBIOTICS, ION-CHELATING AGENTS, AND BUFFERS
#263Stable pharmaceutical composition comprising beta-lactam antibiotic and ion-chelating agent
#264Composition and Method of Treatment of Bacterial Infections
#265Gastrointestinal absorption enhancer mediated by proton-coupled transporter and its preparing method
#266Methods of treating a subject suffering from irritable bowel syndrome
#267Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism
#268Method of treating gastrointestinal diseases associated with species of genus
#269Biodegradable, polymer coverings for breast implants
#270Probiotic, lactic acid-producing bacteria and uses thereof
#271Treatment and Control of Severe Infections Including Cystic Fibrosis
#272METHOD OF TREATING MIDDLE EAR INFECTIONS
#273Therapeutic compositions
#274Methods for treatment and management of macular degeneration using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
#275Neurotherapeutic compositions and method
#276Cross-linked glycopeptide-cephalosporin antibiotics
#277Cross-linked glycopeptide-cephalosporin antibiotics
#278Antibiotic product formulation
#279Target for therapy of cognitive impairment
#280Oral neurotherapeutic cephalosporin sulfoxide and sulfone-containing compositions
#281Gastrointestinal Absorption Enhancer Mediated By Proton-Coupled Transporter and Its Preparing Method
#282Cross-linked glycopeptide-cephalosporin antibiotics
#283Method of Stabilizing Disordered Cefovecin Sodium Salt
#284ADMINISTRATION OF SLEEP RESTORATIVE AGENTS
#285STABLE SOLID DOSAGE FORM CONTAINING AMORPHOUS CEFDITOREN PIVOXIL AND PROCESS FOR PREPARATION THEREOF
#286Cross-linked glycopeptide-cephalosporin antibiotics
#287Fast release dosage forms for antibiotics
#288Cross-linked glycopeptide-cephalosporin antibiotics
#289Cross-linked glycopeptide-cephalosporin antibiotics
#290Cross-linked glycopeptide-cephalosporin antibiotics
#291Novel Composition for a Topical Skin Treatment Base and Medicated Applications Thereof
#292Methods of treating diarrhea and bloating caused by small intestinal bacterial overgrowth
#293Methods of treating fibromyalgia caused by small intestinal bacterial overgrowth
#294Methods and compositions for the treatment of diseases or conditions associated with increased C-reactive protein, interleukin-6, or interferon-gamma levels
#295Treating cystic fibrosis with antibiotics via an aerosol drug
#296Treating cystic fibrosis with antibiotics via a swirler delivery
#297Flashmelt oral dosage formulation
#298Perorally administrable antimicrobial composition
#299Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
#300Neurotherapeutic composition and method therefor